Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Oncology, inflammation and infectious diseases focused Tiziana Life Sciences has announced that former subsidiary Accustem Sciences is to list in the US.
The company said that Accustem Sciences intends to file a listing application with the Nasdaq Stock Market shortly after completion of the distribution of shares in Accustem to Tiziana Life Sciences shareholders.
Tiziana Life Sciences said: 'The board of directors of Accustem has resolved that the Nasdaq listing venue is more appropriate to the nature of Accustem's business.'
At 1:24pm: (LON:TILS) Tiziana Life Sciences Plc share price was 0p at 92p